Last updated: 4 August 2023 at 6:57pm EST

Dr. Stephen Gould Ph.D. Net Worth




The estimated Net Worth of Stephen E Gould is at least 6.43 千$ dollars as of 2 August 2023. Dr Gould owns over 4,076 units of Atreca Inc stock worth over 2,558$ and over the last 2 years he sold BCEL stock worth over 3,872$.

Dr D BCEL stock SEC Form 4 insiders trading

Dr has made over 1 trades of the Atreca Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 4,076 units of BCEL stock worth 3,872$ on 2 August 2023.

The largest trade he's ever made was selling 4,076 units of Atreca Inc stock on 2 August 2023 worth over 3,872$. On average, Dr trades about 1,359 units every 0 days since 2022. As of 2 August 2023 he still owns at least 28,424 units of Atreca Inc stock.

You can see the complete history of Dr Gould stock trades at the bottom of the page.





Dr. Stephen Gould Ph.D. biography

Dr. Stephen Gould Ph.D. is the Chief Scientific Officer at Atreca Inc.



What's Dr D's mailing address?

Stephen's mailing address filed with the SEC is 835 INDUSTRIAL ROAD, SUITE 400, , SAN CARLOS, CA, 94070.

Insiders trading at Atreca Inc

Over the last 5 years, insiders at Atreca Inc have traded over 4,571,843$ worth of Atreca Inc stock and bought 6,001 units worth 76,740$ . The most active insiders traders include Group, Llc Green Jeremy Red...Bros. Advisors Lp Baker Bro...Harbor Master Investors (Ca.... On average, Atreca Inc executives and independent directors trade stock every 20 days with the average trade being worth of 991$. The most recent stock trade was executed by John A Orwin on 11 April 2024, trading 1 units of BCEL stock currently worth 0$.



What does Atreca Inc do?

atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. with its immune repertoire capture™ (irc™) technology, atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. if you are interested in becoming part of the atreca team, our open positions can be found at: http://www.atreca.com/careers/



Complete history of Dr Gould stock trades at Atreca Inc

インサイダー
取引
取引
合計金額
Stephen E Gould
Chief Scientific Officer
販売 3,872$
2 Aug 2023


Atreca Inc executives and stock owners

Atreca Inc executives and other stock owners filed with the SEC include: